Physician profile
Daniel K Kim
NPI 1427581016
$3,158.65
in general payments reported to CMS, 2019-2025
8 companies · $198 in 2025
The $198 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $142 · 2021: $600 · 2022: $82.81 · 2023: $92.86 · 2024: $2,044 · 2025: $198.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,244 · Food and Beverage: $1,090.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,243.83 |
| Food and Beverage | $1,090.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $1,471.32 | 2024 | |
| Stryker Corporation | $469.44 | 2021-2024 | Augment Injectable, Infinity, Citrefix |
| Smith+Nephew, INC. | $445.02 | 2020-2022 | |
| Evolution Surgical, INC | $411.51 | 2024 | |
| Surgenex LLC | $173.61 | 2025 | Surmatrix, Pellograft, Renograft |
| Organogenesis INC. | $133.49 | 2021-2023 | Puraply |
| Treace Medical Concepts, INC. | $30.17 | 2024 | |
| Bioventus LLC | $24.09 | 2025 | Exogen Ultrasound Bone Healing System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Kim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.